Diagnostic Specialty Enzymes Market 2027 by Product, Application, End User and Geography | The Insight Partners

Diagnostic Specialty Enzymes Market to 2027 - Global Analysis and Forecasts By Product (Polymerases and Nucleases, Carbohydrases, Proteases, Oxidases, Ligases, Others); Application (Molecular Diagnostics, Clinical Chemistry, Research Studies, Others); End User (Pharamceutical and Biotechnological Companies, Hospitals and Clinical Laboratories, Diagnostic Laboratories, Research Institutes); and Geography

Report Code: TIPRE00006864 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Specialty enzymes are the reagents or chemicals that act as catalyst and helps to enhance the biochemical reactions. The use of these enzymes are done in the pharmaceutical, biotechnological, nutraceutical and other industries for application such as drug formulation and others. These enzymes are used to diagnose various diseases such as cancer, cardiovascular diseases and other genetic disorders. The diagnostic specialty enzymes are widely used in the research industries that enables various other related industries to innovate products and services.

MARKET DYNAMICS

The diagnostic specialty enzymes market is expected to grow during the forecast period due to the factors such as rising genetic disorders, increasing biopharmaceutical productions, growing clinical diagnostics through molecular based products and others. The rising healthcare industry in the emerging regions are likely to serve several growth opportunities during the forecast period.

MARKET SCOPE

The "Global Diagnostic Specialty Enzymes Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of diagnostic specialty enzymes market with detailed market segmentation by product, application, end user and geography. The global diagnostic specialty enzymes market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading diagnostic specialty enzymes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global diagnostic specialty enzymes market is segmented on the basis of product, application and end user. Based on the product segment, market is divided into polymerases and nucleases, carbohydrases, proteases, oxidases, ligases, and others. Based on the application the market is classified as molecular diagnostics, clinical chemistry, research studies, and others. On the basis on end user the market is segmented as pharamceutical and biotechnological companies, hospitals and clinical laboratories, diagnostic laboratories, and research institutes.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global diagnostic specialty enzymes market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diagnostic specialty enzymes market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diagnostic specialty enzymes market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diagnostic specialty enzymes market in these regions.


MARKET PLAYERS


The reports cover key developments in the diagnostic specialty enzymes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from diagnostic specialty enzymes market are anticipated to lucrative growth opportunities in the future with the rising demand for diagnostic specialty enzymes market in the global market. Below mentioned is the list of few companies engaged in the diagnostic specialty enzymes market.

The report also includes the profiles of key diagnostic specialty enzymes market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novozymes A/S
  •  Codexis, Inc.
  •  Biocatalysts Ltd.
  •  Advanced Enzymes Technologies Ltd.
  •  BBI Solutions
  •  Affymetrix, Inc.
  •  F. Hoffmann-La Roche Ltd.
  •  Amano Enzymes, Inc.
  •  Amicogen, Inc.
  •  American Laboratories
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Table of Content

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diagnostic Specialty Enzymes - By Product
1.3.2 Diagnostic Specialty Enzymes - By Application
1.3.3 Diagnostic Specialty Enzymes - By End User
1.3.4 Diagnostic Specialty Enzymes - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. DIAGNOSTIC SPECIALTY ENZYMES LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. DIAGNOSTIC SPECIALTY ENZYMES - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. DIAGNOSTIC SPECIALTY ENZYMES - GLOBAL MARKET ANALYSIS

6.1. DIAGNOSTIC SPECIALTY ENZYMES - GLOBAL MARKET OVERVIEW
6.2. DIAGNOSTIC SPECIALTY ENZYMES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. DIAGNOSTIC SPECIALTY ENZYMES - REVENUE AND FORECASTS TO 2027 - PRODUCT

7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. POLYMERASES AND NUCLEASES
7.3.1. Overview
7.3.2. Polymerases and Nucleases Market Forecast and Analysis
7.4. CARBOHYDRASES
7.4.1. Overview
7.4.2. Carbohydrases Market Forecast and Analysis
7.5. PROTEASES
7.5.1. Overview
7.5.2. Proteases Market Forecast and Analysis
7.6. OXIDASES
7.6.1. Overview
7.6.2. Oxidases Market Forecast and Analysis
7.7. LIGASES
7.7.1. Overview
7.7.2. Ligases Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis

8. DIAGNOSTIC SPECIALTY ENZYMES - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. CLINICAL CHEMISTRY
8.4.1. Overview
8.4.2. Clinical Chemistry Market Forecast and Analysis
8.5. RESEARCH STUDIES
8.5.1. Overview
8.5.2. Research Studies Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis

9. DIAGNOSTIC SPECIALTY ENZYMES - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARAMCEUTICAL AND BIOTECHNOLOGICAL COMPANIES
9.3.1. Overview
9.3.2. Pharamceutical and Biotechnological Companies Market Forecast and Analysis
9.4. HOSPITALS AND CLINICAL LABORATORIES
9.4.1. Overview
9.4.2. Hospitals and Clinical Laboratories Market Forecast and Analysis
9.5. DIAGNOSTIC LABORATORIES
9.5.1. Overview
9.5.2. Diagnostic Laboratories Market Forecast and Analysis
9.6. RESEARCH INSTITUTES
9.6.1. Overview
9.6.2. Research Institutes Market Forecast and Analysis

10. DIAGNOSTIC SPECIALTY ENZYMES REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Diagnostic Specialty Enzymes Overview
10.1.2 North America Diagnostic Specialty Enzymes Forecasts and Analysis
10.1.3 North America Diagnostic Specialty Enzymes Forecasts and Analysis - By Product
10.1.4 North America Diagnostic Specialty Enzymes Forecasts and Analysis - By Application
10.1.5 North America Diagnostic Specialty Enzymes Forecasts and Analysis - By End User
10.1.6 North America Diagnostic Specialty Enzymes Forecasts and Analysis - By Countries
10.1.6.1 United States Diagnostic Specialty Enzymes
10.1.6.1.1 United States Diagnostic Specialty Enzymes by Product
10.1.6.1.2 United States Diagnostic Specialty Enzymes by Application
10.1.6.1.3 United States Diagnostic Specialty Enzymes by End User
10.1.6.2 Canada Diagnostic Specialty Enzymes
10.1.6.2.1 Canada Diagnostic Specialty Enzymes by Product
10.1.6.2.2 Canada Diagnostic Specialty Enzymes by Application
10.1.6.2.3 Canada Diagnostic Specialty Enzymes by End User
10.1.6.3 Mexico Diagnostic Specialty Enzymes
10.1.6.3.1 Mexico Diagnostic Specialty Enzymes by Product
10.1.6.3.2 Mexico Diagnostic Specialty Enzymes by Application
10.1.6.3.3 Mexico Diagnostic Specialty Enzymes by End User
10.2. EUROPE
10.2.1 Europe Diagnostic Specialty Enzymes Overview
10.2.2 Europe Diagnostic Specialty Enzymes Forecasts and Analysis
10.2.3 Europe Diagnostic Specialty Enzymes Forecasts and Analysis - By Product
10.2.4 Europe Diagnostic Specialty Enzymes Forecasts and Analysis - By Application
10.2.5 Europe Diagnostic Specialty Enzymes Forecasts and Analysis - By End User
10.2.6 Europe Diagnostic Specialty Enzymes Forecasts and Analysis - By Countries
10.2.6.1 Germany Diagnostic Specialty Enzymes
10.2.6.1.1 Germany Diagnostic Specialty Enzymes by Product
10.2.6.1.2 Germany Diagnostic Specialty Enzymes by Application
10.2.6.1.3 Germany Diagnostic Specialty Enzymes by End User
10.2.6.2 France Diagnostic Specialty Enzymes
10.2.6.2.1 France Diagnostic Specialty Enzymes by Product
10.2.6.2.2 France Diagnostic Specialty Enzymes by Application
10.2.6.2.3 France Diagnostic Specialty Enzymes by End User
10.2.6.3 Italy Diagnostic Specialty Enzymes
10.2.6.3.1 Italy Diagnostic Specialty Enzymes by Product
10.2.6.3.2 Italy Diagnostic Specialty Enzymes by Application
10.2.6.3.3 Italy Diagnostic Specialty Enzymes by End User
10.2.6.4 Spain Diagnostic Specialty Enzymes
10.2.6.4.1 Spain Diagnostic Specialty Enzymes by Product
10.2.6.4.2 Spain Diagnostic Specialty Enzymes by Application
10.2.6.4.3 Spain Diagnostic Specialty Enzymes by End User
10.2.6.5 United Kingdom Diagnostic Specialty Enzymes
10.2.6.5.1 United Kingdom Diagnostic Specialty Enzymes by Product
10.2.6.5.2 United Kingdom Diagnostic Specialty Enzymes by Application
10.2.6.5.3 United Kingdom Diagnostic Specialty Enzymes by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Diagnostic Specialty Enzymes Overview
10.3.2 Asia-Pacific Diagnostic Specialty Enzymes Forecasts and Analysis
10.3.3 Asia-Pacific Diagnostic Specialty Enzymes Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Diagnostic Specialty Enzymes Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Diagnostic Specialty Enzymes Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Diagnostic Specialty Enzymes Forecasts and Analysis - By Countries
10.3.6.1 Australia Diagnostic Specialty Enzymes
10.3.6.1.1 Australia Diagnostic Specialty Enzymes by Product
10.3.6.1.2 Australia Diagnostic Specialty Enzymes by Application
10.3.6.1.3 Australia Diagnostic Specialty Enzymes by End User
10.3.6.2 China Diagnostic Specialty Enzymes
10.3.6.2.1 China Diagnostic Specialty Enzymes by Product
10.3.6.2.2 China Diagnostic Specialty Enzymes by Application
10.3.6.2.3 China Diagnostic Specialty Enzymes by End User
10.3.6.3 India Diagnostic Specialty Enzymes
10.3.6.3.1 India Diagnostic Specialty Enzymes by Product
10.3.6.3.2 India Diagnostic Specialty Enzymes by Application
10.3.6.3.3 India Diagnostic Specialty Enzymes by End User
10.3.6.4 Japan Diagnostic Specialty Enzymes
10.3.6.4.1 Japan Diagnostic Specialty Enzymes by Product
10.3.6.4.2 Japan Diagnostic Specialty Enzymes by Application
10.3.6.4.3 Japan Diagnostic Specialty Enzymes by End User
10.3.6.5 South Korea Diagnostic Specialty Enzymes
10.3.6.5.1 South Korea Diagnostic Specialty Enzymes by Product
10.3.6.5.2 South Korea Diagnostic Specialty Enzymes by Application
10.3.6.5.3 South Korea Diagnostic Specialty Enzymes by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Diagnostic Specialty Enzymes Overview
10.4.2 Middle East and Africa Diagnostic Specialty Enzymes Forecasts and Analysis
10.4.3 Middle East and Africa Diagnostic Specialty Enzymes Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Diagnostic Specialty Enzymes Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Diagnostic Specialty Enzymes Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Diagnostic Specialty Enzymes Forecasts and Analysis - By Countries
10.4.6.1 South Africa Diagnostic Specialty Enzymes
10.4.6.1.1 South Africa Diagnostic Specialty Enzymes by Product
10.4.6.1.2 South Africa Diagnostic Specialty Enzymes by Application
10.4.6.1.3 South Africa Diagnostic Specialty Enzymes by End User
10.4.6.2 Saudi Arabia Diagnostic Specialty Enzymes
10.4.6.2.1 Saudi Arabia Diagnostic Specialty Enzymes by Product
10.4.6.2.2 Saudi Arabia Diagnostic Specialty Enzymes by Application
10.4.6.2.3 Saudi Arabia Diagnostic Specialty Enzymes by End User
10.4.6.3 U.A.E Diagnostic Specialty Enzymes
10.4.6.3.1 U.A.E Diagnostic Specialty Enzymes by Product
10.4.6.3.2 U.A.E Diagnostic Specialty Enzymes by Application
10.4.6.3.3 U.A.E Diagnostic Specialty Enzymes by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Diagnostic Specialty Enzymes Overview
10.5.2 South and Central America Diagnostic Specialty Enzymes Forecasts and Analysis
10.5.3 South and Central America Diagnostic Specialty Enzymes Forecasts and Analysis - By Product
10.5.4 South and Central America Diagnostic Specialty Enzymes Forecasts and Analysis - By Application
10.5.5 South and Central America Diagnostic Specialty Enzymes Forecasts and Analysis - By End User
10.5.6 South and Central America Diagnostic Specialty Enzymes Forecasts and Analysis - By Countries
10.5.6.1 Brazil Diagnostic Specialty Enzymes
10.5.6.1.1 Brazil Diagnostic Specialty Enzymes by Product
10.5.6.1.2 Brazil Diagnostic Specialty Enzymes by Application
10.5.6.1.3 Brazil Diagnostic Specialty Enzymes by End User
10.5.6.2 Argentina Diagnostic Specialty Enzymes
10.5.6.2.1 Argentina Diagnostic Specialty Enzymes by Product
10.5.6.2.2 Argentina Diagnostic Specialty Enzymes by Application
10.5.6.2.3 Argentina Diagnostic Specialty Enzymes by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. DIAGNOSTIC SPECIALTY ENZYMES, KEY COMPANY PROFILES

12.1. NOVOZYMES A/S
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CODEXIS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOCATALYSTS LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ADVANCED ENZYMES TECHNOLOGIES LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BBI SOLUTIONS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AFFYMETRIX, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMANO ENZYMES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AMICOGEN, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMERICAN LABORATORIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novozymes A/S
2. Codexis, Inc.
3. Biocatalysts Ltd.
4. Advanced Enzymes Technologies Ltd.
5. BBI Solutions
6. Affymetrix, Inc.
7. F. Hoffmann-La Roche Ltd.
8. Amano Enzymes, Inc.
9. Amicogen, Inc.
10. American Laboratories